STANDARD BIOTOOLS INC (LAB) Institutional Ownership Changes & 13F Activity
STANDARD BIOTOOLS INC (LAB). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Long Focus Capital Management, Llc, Qube Research & Technologies Ltd, Mak Capital One Llc, D. E. Shaw & Co., Inc., and Barclays Plc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| M&T Bank Corp | Sell | -23,643 | -100.0% | 0 | $0.00 | Q2 2026 | Sep 04, 2026 |
| Citadel Advisors Llc | Buy | +1,123,260 | +91.7% | 2,348,570 | $1.93M | Q2 2026 | Sep 02, 2026 |
| Corient Private Wealth Llc | Buy | +11,694 | +89.6% | 24,740 | $20.35K | Q2 2026 | Aug 27, 2026 |
| Mercer Global Advisors Inc | Buy | +38,604 | +61.5% | 101,381 | $83.41K | Q2 2026 | Aug 19, 2026 |
| Public Employees Retirement System Of Ohio | Buy | +51,900 | — | 51,900 | $41.91K | Q2 2026 | Aug 17, 2026 |
| Jefferies Financial Group Inc. | Buy | +17,675 | — | 17,675 | $14.54K | Q2 2026 | Aug 17, 2026 |
| Transamerica Financial Advisors, Llc | Buy | +658 | — | 658 | $541.00 | Q2 2026 | Aug 17, 2026 |
| Long Focus Capital Management, Llc | Buy | +7,484,279 | +46.7% | 23,500,000 | $19.33M | Q2 2026 | Aug 14, 2026 |
| Qube Research & Technologies Ltd | Buy | +4,116,056 | +584.3% | 4,820,463 | $3.97M | Q2 2026 | Aug 14, 2026 |
| Mak Capital One Llc | Buy | +2,641,278 | +10.1% | 28,813,904 | $23.71M | Q2 2026 | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | Buy | +2,618,942 | +1315.5% | 2,818,026 | $2.32M | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Sell | -2,574,050 | -98.3% | 43,919 | $36.13K | Q2 2026 | Aug 14, 2026 |
| Jane Street Group, Llc | Buy | +2,514,299 | — | 2,514,299 | $2.07M | Q2 2026 | Aug 14, 2026 |
| Mink Brook Asset Management Llc | Buy | +2,190,973 | — | 2,190,973 | $1.80M | Q2 2026 | Aug 14, 2026 |
| Jacobs Levy Equity Management, Inc | Buy | +1,633,112 | — | 1,633,112 | $1.34M | Q2 2026 | Aug 14, 2026 |
| Royce & Associates Lp | Buy | +1,519,804 | +50.6% | 4,525,333 | $3.72M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Buy | +1,410,650 | +67.1% | 3,512,665 | $2.89M | Q2 2026 | Aug 14, 2026 |
| Loews Corp | Buy | +1,250,000 | — | 1,250,000 | $1.03M | Q2 2026 | Aug 14, 2026 |
| Man Group Plc | Buy | +742,793 | — | 742,793 | $611.10K | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Sell | -726,763 | -77.1% | 216,422 | $178.05K | Q2 2026 | Aug 14, 2026 |
| Point72 Asset Management, L.P. | Buy | +663,270 | +1483.1% | 707,991 | $582.46K | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Sell | -655,661 | -27.2% | 1,759,038 | $1.45M | Q2 2026 | Aug 14, 2026 |
| Aster Capital Management (Difc) Ltd | Buy | +541,130 | — | 541,130 | $445.19K | Q2 2026 | Aug 14, 2026 |
| Jain Global Llc | Buy | +467,317 | — | 467,317 | $384.46K | Q2 2026 | Aug 14, 2026 |
| Aqr Capital Management Llc | Buy | +425,920 | +45.6% | 1,359,018 | $1.12M | Q2 2026 | Aug 14, 2026 |
| Sone Capital Management, Llc | Buy | +366,850 | +20.8% | 2,133,631 | $1.76M | Q2 2026 | Aug 14, 2026 |
| Susquehanna Portfolio Strategies, Llc | Buy | +291,513 | — | 291,513 | $239.83K | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Buy | +280,953 | +183.2% | 434,296 | $357.30K | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Buy | +277,375 | — | 277,375 | $228.20K | Q2 2026 | Aug 14, 2026 |
| Hsbc Holdings Plc | Buy | +271,523 | — | 271,523 | $218.77K | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about LAB activity
Which institutional owners are buying LAB?
Institutional owners buying LAB include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in LAB activity?
"Buy" means an investor increased their reported position in LAB compared to the prior reporting period. This reflects growing exposure to STANDARD BIOTOOLS INC (LAB) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in LAB increasing?
Institutional interest in LAB can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related LAB Institutional Insights
- LAB Overview
- LAB 13F Institutional Holders
- LAB Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- LAB Insider Trading & SEC Form 4 Activity
- LAB Articles
- Top Institutional Investor Stock Rankings